Published in Crit Care Med on November 01, 2007
Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology (2011) 2.61
Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis. Liver Transpl (2015) 2.44
Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology (2012) 2.31
Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med (2012) 2.13
Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. Crit Care Med (2014) 1.50
Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol (2014) 1.45
Encephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapy. Crit Care Med (2011) 1.43
Management of acute liver failure. Nat Rev Gastroenterol Hepatol (2009) 1.32
Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr (2010) 1.29
Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology (2010) 1.28
Hypothermia for acute brain injury--mechanisms and practical aspects. Nat Rev Neurol (2012) 1.28
Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics (2010) 1.19
Psychiatric aspects of organ transplantation in critical care. Crit Care Clin (2008) 1.11
Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol (2012) 1.05
Drug-induced acute liver failure. Clin Liver Dis (2013) 1.03
Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study. Int J Med Sci (2013) 0.89
Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int (2014) 0.89
Intracranial hemorrhage. Am J Respir Crit Care Med (2011) 0.86
Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. Liver Transpl (2013) 0.84
Epidemiological and clinical features of hepatitis B virus related liver failure in China. World J Gastroenterol (2011) 0.83
Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder. World J Gastroenterol (2009) 0.83
EEG monitoring during therapeutic hypothermia in neonates, children, and adults. Am J Electroneurodiagnostic Technol (2011) 0.83
Acute liver failure and liver transplantation. Intractable Rare Dis Res (2013) 0.81
Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit (2011) 0.81
Acute liver failure in pregnancy: Challenges and management. Indian J Anaesth (2015) 0.81
Mild hypothermia does not affect liver regeneration after partial hepatectomy in mice. Liver Int (2008) 0.80
Neurological complications of solid organ transplantation. Neurohospitalist (2013) 0.80
Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA. BMJ Open (2015) 0.80
Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models. PLoS One (2015) 0.79
Acute fatty liver of pregnancy: over six months follow-up study of twenty-five patients. World J Gastroenterol (2015) 0.79
[Ruptured subcapsular hematoma of the liver complicating acute fatty liver of pregnancy]. Pan Afr Med J (2014) 0.79
Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol (2016) 0.79
Outcomes of Children With and Without Hepatic Encephalopathy From the Pediatric Acute Liver Failure Study Group. J Pediatr Gastroenterol Nutr (2016) 0.78
Evaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in-vivo proton MR spectroscopy. World J Gastroenterol (2008) 0.77
A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels. Liver Int (2011) 0.77
Acute changes in ventricular volume during treatment for hepatic and renal failure. Neurol Clin Pract (2014) 0.77
Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States. Liver Transpl (2016) 0.77
Clinical review: use of renal replacement therapies in special groups of ICU patients. Crit Care (2012) 0.77
Hypoxic Hepatitis: A Review and Clinical Update. J Clin Transl Hepatol (2016) 0.77
Prognostic impact of ICG-PDR in patients with hypoxic hepatitis. Ann Intensive Care (2015) 0.76
23.4% Saline Decreases Brain Tissue Volume in Severe Hepatic Encephalopathy as Assessed by a Quantitative CT Marker. Crit Care Med (2016) 0.76
Coagulopathy in liver disease: Lack of an assessment tool. World J Gastroenterol (2015) 0.76
Surgical intensive care unit--the trauma surgery perspective. Langenbecks Arch Surg (2011) 0.75
Acute liver failure caused by severe acute hepatitis B: a case series from a multi-center investigation. Ann Clin Microbiol Antimicrob (2014) 0.75
Therapeutic hypothermia for acute neurological injuries. Neurotherapeutics (2012) 0.75
Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit. PLoS One (2016) 0.75
Acute brain injury and therapeutic hypothermia in the PICU: A rehabilitation perspective. J Pediatr Rehabil Med (2009) 0.75
Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure. Liver Transpl (2015) 0.75
Clinical management of acute liver failure: Results of an international multi-center survey. World J Gastroenterol (2016) 0.75
Recent advances in management of acute liver failure. Indian J Crit Care Med (2015) 0.75
Heat stroke leading to acute liver injury & failure: A case series from the Acute Liver Failure Study Group. Liver Int (2017) 0.75
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med (2009) 14.31
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med (2008) 9.33
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (2003) 8.75
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med (2014) 7.73
Liver biopsy. Hepatology (2009) 7.61
Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology (2002) 7.53
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet (2006) 7.53
Economic and health consequences of selling a kidney in India. JAMA (2002) 6.58
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology (2008) 6.15
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology (2010) 6.14
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology (2002) 5.48
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology (2008) 5.45
AASLD position paper: the management of acute liver failure. Hepatology (2005) 5.09
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology (2009) 4.90
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A (2006) 4.84
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int (2009) 4.72
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology (2004) 4.27
Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N Engl J Med (2009) 4.21
Disparities in liver transplantation before and after introduction of the MELD score. JAMA (2008) 4.10
Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology (2014) 4.01
Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology (2005) 3.95
Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology (2009) 3.88
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology (2006) 3.85
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology (2009) 3.50
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf (2009) 3.48
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials (2004) 3.46
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol (2013) 3.41
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology (2007) 3.40
Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology (2010) 3.35
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol (2005) 3.18
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology (2003) 3.09
Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology (2008) 3.04
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med (2015) 2.97
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology (2002) 2.96
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol (2010) 2.96
Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics (2006) 2.96
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol (2012) 2.89
Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int (2011) 2.72
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology (2008) 2.69
Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology (2011) 2.64
Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc (2009) 2.63
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol (2005) 2.63
Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl (2005) 2.63
Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis. Dig Dis Sci (2014) 2.62
Acute kidney injury: an increasing global concern. Lancet (2013) 2.61
Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology (2011) 2.61
Acute kidney injury: global health alert. Kidney Int (2013) 2.57
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev (2012) 2.57
Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2006) 2.56
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy. Hepatology (2010) 2.53
Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int (2004) 2.52
Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care (2010) 2.51
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology (2010) 2.47
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology (2008) 2.44
Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis. Liver Transpl (2015) 2.44
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology (2004) 2.44
The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc (2006) 2.43
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant (2010) 2.36
Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl (2007) 2.31
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology (2010) 2.30
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology (2012) 2.26
Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology (2010) 2.26
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology (2011) 2.25
Steroid use in acute liver failure. Hepatology (2013) 2.23
Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis (2009) 2.22
Glycogen storage disease type III diagnosis and management guidelines. Genet Med (2010) 2.13
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol (2009) 2.06
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology (2006) 2.06
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology (2010) 2.06
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology (2003) 2.05
Virologic response and resistance to adefovir in patients with chronic hepatitis B. J Hepatol (2005) 2.04
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology (2011) 2.01